Fulcrum Therapeutics Inc [NASDAQ: FULC] closed the trading session at $4.00.
The stocks have a year to date performance of -40.74 percent and weekly performance of 15.94 percent. The stock has been moved at -57.72 percent over the last six months. The stock has performed -54.83 percent around the most recent 30 days and changed -36.31 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 1.71M shares, FULC reached to a volume of 7629778 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Fulcrum Therapeutics Inc [FULC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FULC shares is $5.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FULC stock is a recommendation set at 2.62. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Fulcrum Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on September 13, 2024. The new note on the price target was released on September 12, 2024, representing the official price target for Fulcrum Therapeutics Inc stock. Previously, the target price had yet another drop from $15 to $4, while RBC Capital Mkts kept a Sector Perform rating on FULC stock.
The Average True Range (ATR) for Fulcrum Therapeutics Inc is set at 0.71, with the Price to Sales ratio for FULC stock in the period of the last 12 months amounting to 3.06. The Price to Book ratio for the last quarter was 0.91, with the Price to Cash per share for the same quarter was set at 4.39.
FULC stock trade performance evaluation
Fulcrum Therapeutics Inc [FULC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.94. With this latest performance, FULC shares dropped by -54.83% in over the last four-week period, additionally sinking by -57.72% over the last 6 months – not to mention a drop of -9.30% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for FULC stock in for the last two-week period is set at 33.68, with the RSI for the last a single of trading hit 36.02, and the three-weeks RSI is set at 34.83 for Fulcrum Therapeutics Inc [FULC]. The present Moving Average for the last 50 days of trading for this stock 7.63, while it was recorded at 3.45 for the last single week of trading, and 7.85 for the last 200 days.
Fulcrum Therapeutics Inc [FULC]: An insightful look at the core fundamentals
Fulcrum Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 22.07 and a Current Ratio set at 22.07.
Earnings per share (EPS) analysis for Fulcrum Therapeutics Inc [FULC] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for FULC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Fulcrum Therapeutics Inc go to 16.40%.
Fulcrum Therapeutics Inc [FULC]: Institutional Ownership
There are presently around $99.67%, or 101.31%% of FULC stock, in the hands of institutional investors. The top three institutional holders of FULC stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 11.61 million shares, which is approximately 18.7302%. RTW INVESTMENTS, LP, holding 5.85 million shares of the stock with an approximate value of $$36.24 million in FULC stocks shares; and RTW INVESTMENTS, LP, currently with $$33.05 million in FULC stock with ownership which is approximately 8.5989%.
